[1]
“Evaluating Fluoxetine’s Growth-Inhibitory Impact on Clinical Isolates of Enteric Bacteria: Harnessing Repurposing Potential”, MIC, vol. 2, no. 2, pp. 89–96, Dec. 2023, doi: 10.55627/mic.002.02.0454.